Preprint · OA
via OpenAlex
Pharmacological Targeting of Senescence with Senolytics as a New Therapeutic Strategy for Neurodegeneration
Miriam Richardson, Des R. Richardson
Molecular Pharmacology · 2023 · ▲ 47 citations
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1124/molpharm.123.000803
- Canonical
- link ↗
- Fetched
- 2026-09-19 MST
Cite this
APA
Richardson, M., & Richardson, D.R. (2023). Pharmacological Targeting of Senescence with Senolytics as a New Therapeutic Strategy for Neurodegeneration. <em>Molecular Pharmacology</em>. https://doi.org/10.1124/molpharm.123.000803
Vancouver
Richardson M, Richardson DR. Pharmacological Targeting of Senescence with Senolytics as a New Therapeutic Strategy for Neurodegeneration. Molecular Pharmacology. 2023. doi:10.1124/molpharm.123.000803.
BibTeX
@unpublished{miriam2023Pharma,
title = {Pharmacological Targeting of Senescence with Senolytics as a New Therapeutic Strategy for Neurodegeneration},
author = {Miriam Richardson and Des R. Richardson},
journal = {Molecular Pharmacology},
year = {2023},
doi = {10.1124/molpharm.123.000803},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Nature Reviews Drug Discovery 2019
Preprint · OA
Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases
International Journal of Molecular Sciences 2021
Open access · CC-BY
Senolytics: A Novel Strategy for Neuroprotection in ALS?
Journal of Hepatology 2025
Preprint · OA
Cellular senescence in liver diseases: From molecular drivers to therapeutic targeting
International journal of molecular sciences 2026
Open access · OA
Cellular Senescence and the SASP in HFpEF: Pathogenic Mechanisms and Therapeutic Targeting
Journal of Clinical Investigation 2013
Open access · OA
Cellular senescence and the senescent secretory phenotype: therapeutic opportunities
Pharmacology & Therapeutics 2015
Citation only